FDA Adverse Event Injury Summary report: N

RSP SHOULDER

MDR report key: 3863889 · Received June 10, 2014

Report

Report Number
1644408-2014-00354
Event Type
Injury
Date Received
June 10, 2014
Date of Event
June 5, 2014
Report Date
June 5, 2014
Manufacturer
ENCORE MEDICAL, L.P.
Product Code
KWS
PMA / PMN Number
K092873
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE REASON FOR THIS REVISION SURGERY WAS THE PATIENT'S GLENOSPHERE DISASSOCIATED FROM THE BASEPLATE. THE HEALTHCARE PROFESSIONAL INDICATED THERE WAS NO DELAY IN SURGERY AND ANOTHER SUITABLE DEVICE WAS AVAILABLE FOR USE. THE REVISION SURGERY WAS COMPLETED AS INTENDED. THE DEVICE WAS DISPOSED OF AT THE HOSPITAL AND NOT MADE AVAILABLE TO DJO SURGICAL FOR EXAMINATION. A REVIEW OF THE DEVICE HISTORY RECORDS SHOWED NO NON-CONFORMING MATERIAL REPORTS ASSOCIATED WITH THIS PRODUCT. A REVIEW OF THE PRODUCT COMPLAINT REPORT HISTORY SHOWED THERE ARE 7 PRIOR COMPLAINTS ON PART NUMBER 508-44-101, RSP GLENOID HEAD. (B)(4). THIS INVESTIGATION IS LIMITED IN SCOPE BECAUSE THE EXPLANTED PRODUCTS WERE NOT RETURNED TO DJO SURGICAL AND A DEFINITIVE ROOT CAUSE CANNOT BE DETERMINED. FACTORS THAT COULD CONTRIBUTE TO A GLENOID HEAD DISASSOCIATION FROM A BASEPLATE INCLUDE TRAUMA AND EXCESSIVE LOADING OF THE SHOULDER PROSTHESIS SUCH AS CARRYING HEAVY WEIGHT, OR CARRYING A HEAVY EXTENDED LOAD, EXCESSIVE RANGE OF MOTION (ROM), AND IMPROPER TIGHTENING OF GLENOID HEAD RETAINING SCREW. THERE IS NO INFORMATION REPORTED THAT SHOWED A MATERIAL, DESIGN, OR MANUFACTURING PROBLEM WITH THE PRODUCT.

Description of Event or Problem · 1

SECOND REVISION SURGERY - DUE TO THE PATIENT'S GLENOSPHERE DISASSOCIATING FROM THE BASEPLATE. THE SURGEON EXCHANGED THE HEAD AND LINER AND ADDED A REVERSE SHOULDER PROSTHESIS MONOBLOCK SPACER SCREW.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
340823 RSP SHOULDER RSP GLENOID HEAD W/RETAINING SCREW / NEUTRAL 44MM KWS ENCORE MEDICAL, L.P. 877C1010

Patients

Seq Age Sex Outcome Treatment
1 61 YR Required Intervention (B)(4), LOT 925F1000